Episode

Highlights From the American College of Cardiology's 2026 Scientific Sessions

Podcast: JAMA Medical News
Published: Apr 10, 2026
Duration seconds: 1230
Processing state: not_requested
Canonical source: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.2401
Audio: https://traffic.libsyn.com/secure/jamamedicalnews/Highlights_From_the_American_College_of_Cardiologys_2026_Scientific_Sessions_1.mp3?dest-id=525944
JSON: /v1/public/podcasts/jama-medical-news-779603/episodes/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions
Markdown: /podcast/jama-medical-news-779603/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions.md

Actions

POST https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/jama-medical-news-779603/highlights-from-the-american-college-of-cardiology-s-2026-scientific-sessions.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting. Related Content: PCSK9 Inhibitors in Diabetes, Tirzepatide's Cardiorenal Effects, Shingles Vaccine, and More From ACC